John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), to Deliver Keynote Address on the Future of Biotech and Rare Disease Innovation at the 2026 MDA Clinical & Scient ...
The Muscular Dystrophy Association (MDA) announced today that John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), will deliver the keynote address at the 2026 MDA ...
Mere weeks after being named the nation’s top drug regulator, Richard Pazdur, M.D., is taking steps to retire as head of the FDA’s Center for Drug Evaluation and Research at the end of this month, | ...
The FDA has proposed cutting fees for early-stage companies conducting clinical development in the U.S. instead of abroad. | ...
A cascade of announcements and internal leaks has generated a storm of controversy, culminating in the abrupt retirement of ...
DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The 2025 iC (3) (R) Life Science & Healthcare Innovation Summit, hosted by BioNTX, concluded on September 16--17 at the Hilton Anatole in Dallas, marking more ...
Biotechnology is also a vital engine of economic prosperity, generating almost 7% of U.S. private-sector GDP and supporting roughly 10 million jobs across all 50 states. The good news is that we still ...
The 2025 iC³® Life Science & Healthcare Innovation Summit, hosted by BioNTX, concluded on September 16–17 at the Hilton Anatole in Dallas, marking more than a decade of progress, partnership, and ...
Pharmaceutical Technology on MSN
Richard Padzur to leave FDA following recent CDER leadership shift
Tidmarsh’s departure was one of the many leadership changes endured by the FDA in 2025. In July, Center for Biologics ...
FDA Commissioner Marty Makary has appointed Tracy Beth Høeg as acting director of the Center for Drug Evaluation and Research ...
Cross Country said its co-founder and chairman, Kevin Clark, has returned to the helm as president and CEO, posts he had ceded to Martins in 2022. Clark co-founded the company in 1986.
THURSDAY, Dec. 4, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) is facing even more leadership changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback